欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1541/001
药品名称FERANT
活性成分
    • Palonosetron hydrochloride 250.0 µg
剂型Solution for injection
上市许可持有人Medochemie Ltd, Cyprus
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Greece (GR)
      FERANT
    • Latvia (LV)
      Ferant 250 mikrogrami šķīdums injekcijām
    • Lithuania (LT)
      FERANT 250 mikrogramų injekcinis tirpalas
    • Estonia (EE)
      FERANT
    • Bulgaria (BG)
      Ferant
    • Cyprus (CY)
    • Czechia (CZ)
      FERANT 250 MIKROGRAMŮ INJEKČNÍ ROZTOK
    • Romania (RO)
    • Slovakia (SK)
      FERANT 250 mikrogramov injekčný roztok
    • Malta (MT)
    • Croatia (HR)
      Ferant 250 mikrograma otopina za injekciju
    • Spain (ES)
    • Portugal (PT)
    • Slovenia (SI)
许可日期2016/04/20
最近更新日期2024/12/11
药物ATC编码
    • A04AA05 palonosetron
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase